Expanded Access [11C] Methionine PET Imaging

Available (expanded access)

Conditions studied: Central Nervous System Tumor, Head and Neck Neoplasms

In brief

The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment. Primary Objective To provide expanded access to L-\[11C\]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and head and neck to guide therapeutic management of disease.

Key facts

Study ID

NCT05511714

Run by

St. Jude Children's Research Hospital

Last updated by the study team

2026-04-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All participants under the care of a SJCRH physician with known or suspected neoplastic disease of the CNS or head and neck are eligible for participation.
• No limit on age.
• Patients of all genders and all ethnic groups under the care of a SJCRH physician.
• Female participants of child-bearing age must not be lactating due to theoretical potential harm to the infant from exposure to radiation.
• Informed consent signed by participant, parent, or guardian according to the guidelines of the Institutional Review Board.

You may not qualify if…

• More than six L-[11C]methionine PET scans within the previous 12 months.
• Inability or willingness of patient, parent, or guardian to consent.

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.